Nuvectis Pharma (NVCT) Form 8-K Summary

Date of Event: November 4, 2025

Nuvectis Pharma, Inc. filed this Form 8-K primarily to announce its financial results for the third quarter ended September 30, 2025, via an accompanying press release (Exhibit 99.1).

• Key Action: Furnishing Q3 2025 financial performance update.
• Investor Note: The actual financial metrics (revenue, EPS, cash position, etc.) are contained within Exhibit 99.1, not the 8-K body itself.
• Status: The company confirms its emerging growth company status.

Critical: Investors must revie